PETMED EXPRESS INC PETS
Nasdaq · XNAS · stock · Retail-Drug Stores and Proprietary Stores
Chart by TradingView
2/9
Piotroski F — financial health
-4.59
Altman Z″ — distress risk · distress
0.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $179.0M | -$57.3M | $50.2M | -$33.0M | $28.9M |
| 2025 | $227.0M | -$6.3M | $69.1M | -$395,000 | $85.1M |
| 2024 | $274.1M | -$7.5M | $84.8M | -$194,000 | $96.7M |
| 2023 | $247.6M | $5.1M | $76.5M | $22.5M | $110.0M |
| 2022 | $272.3M | $18.7M | $76.9M | $16.7M | $123.5M |
| 2021 | $309.2M | $30.6M | $89.9M | $37.6M | $124.9M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.59 (distress)
- Working capital / assets -0.104
- Retained earnings / assets 0.114
- EBIT / assets -0.723
- Equity / liabilities 0.554
Source: SEC EDGAR filings · CIK 0001040130 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.